These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Sleep and Cognitive Function in Multiple Sclerosis. Braley TJ; Kratz AL; Kaplish N; Chervin RD Sleep; 2016 Aug; 39(8):1525-33. PubMed ID: 27166237 [TBL] [Abstract][Full Text] [Related]
16. Vision Disturbances in Multiple Sclerosis. Costello F Semin Neurol; 2016 Apr; 36(2):185-95. PubMed ID: 27116725 [TBL] [Abstract][Full Text] [Related]
17. Novel MRI and PET markers of neuroinflammation in multiple sclerosis. Hagens M; van Berckel B; Barkhof F Curr Opin Neurol; 2016 Jun; 29(3):229-36. PubMed ID: 27058220 [TBL] [Abstract][Full Text] [Related]
18. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Martinez-Lapiscina EH; Arnow S; Wilson JA; Saidha S; Preiningerova JL; Oberwahrenbrock T; Brandt AU; Pablo LE; Guerrieri S; Gonzalez I; Outteryck O; Mueller AK; Albrecht P; Chan W; Lukas S; Balk LJ; Fraser C; Frederiksen JL; Resto J; Frohman T; Cordano C; Zubizarreta I; Andorra M; Sanchez-Dalmau B; Saiz A; Bermel R; Klistorner A; Petzold A; Schippling S; Costello F; Aktas O; Vermersch P; Oreja-Guevara C; Comi G; Leocani L; Garcia-Martin E; Paul F; Havrdova E; Frohman E; Balcer LJ; Green AJ; Calabresi PA; Villoslada P; Lancet Neurol; 2016 May; 15(6):574-84. PubMed ID: 27011339 [TBL] [Abstract][Full Text] [Related]
20. Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis. Kappos L; De Stefano N; Freedman MS; Cree BA; Radue EW; Sprenger T; Sormani MP; Smith T; Häring DA; Piani Meier D; Tomic D Mult Scler; 2016 Sep; 22(10):1297-305. PubMed ID: 26585439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]